Loss of PPARγ expression by fibroblasts enhances dermal wound closure

Fibrogenesis and Tissue Repair

Volumn 5, Issue 1, 2012, Pages

  Sha, Wei ^a   Thompson, Katherine ^a   South, Jennifer ^a   Baron, Murray ^b   Leask, Andrew ^a  

^a WESTERN UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; CYCLINE; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE B; SMAD3 PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HOMEOSTASIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SKIN FIBROBLAST; TISSUE REPAIR; WOUND CLOSURE;

EID: 84860651498     PISSN: None     EISSN: 17551536     Source Type: Journal    
DOI: 10.1186/1755-1536-5-5     Document Type: Article

References (21)

1. Tomasek JJ, Gabbiani G, Hinz B, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2003, 3:349-363.
2. Elliott CG, Hamilton DW. Deconstructing fibrosis research: do pro-fibrotic signals point the way for chronic dermal wound regeneration?. J Cell Commun Signal 2011, 5:301-315. 10.1007/s12079-011-0131-5, 3245760, 21503732.
3. Shi-wen X, Eastwood M, Stratton RJ, Denton CP, Leask A, Abraham DJ. Rosiglitazone alleviates the persistent fibrotic phenotype of lesional skin scleroderma fibroblasts. Rheumatology (Oxford) 2010, 49:259-263.
4. Plutzky J. The PPAR-RXR transcriptional complex in the vasculature: energy in the balance. Circ Res 2011, 108:1002-1016. 10.1161/CIRCRESAHA.110.226860, 21493923.
5. Wei J, Bhattacharyya S, Varga J. Peroxisome proliferator-activated receptor γ innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosis. Curr Opin Rheumatol 2010, 22:671-676. 10.1097/BOR.0b013e32833de1a7, 20693905.
6. Burgess HA, Daugherty LE, Thatcher TH, Lakatos HF, Ray DM, Redonnet M, Phipps RP, Sime PJ. PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2005, 288:L1146-L1153. 10.1152/ajplung.00383.2004, 15734787.
7. Wu M, Melichian DS, Chang E, Warner-Blankenship M, Ghosh AK, Varga J. Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma. Am J Pathol 2009, 174:519-533. 10.2353/ajpath.2009.080574, 2630560, 19147827.
8. Ghosh AK, Wei J, Wu M, Varga J. Constitutive Smad signaling and Smad-dependent collagen gene expression in mouse embryonic fibroblasts lacking peroxisome proliferator-activated receptor-gamma. Biochem Biophys Res Commun 2008, 374:231-236. 10.1016/j.bbrc.2008.07.014, 3157939, 18627765.
9. Kapoor M, McCann M, Liu S, Huh K, Denton CP, Abraham DJ, Leask A. Loss of PPARγ in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis. Arthritis Rheum 2009, 60:2822-2829. 10.1002/art.24761, 19714649.
10. Shi-wen X, Stanton LA, Kennedy L, Pala D, Chen Y, Howat SL, Renzoni EA, Carter DE, Bou-Gharios G, Stratton RJ, Pearson JD, Beier F, Lyons KM, Black CM, Abraham DJ, Leask A. CCN2 is necessary for adhesive responses to transforming growth factor-beta1 in embryonic fibroblasts. J Biol Chem 2006, 281:10715-10726. 10.1074/jbc.M511343200, 16484225.
11. Kulkarni AA, Thatcher TH, Olsen KC, Maggirwar SB, Phipps RP, Sime PJ. PPAR-γ ligands repress TGFβ-induced myofibroblast differentiation by targeting the PI3K/Akt pathway: implications for therapy of fibrosis. PLoS One 2011, 6:e15909. 10.1371/journal.pone.0015909, 3017065, 21253589.
12. Xu SW, Liu S, Eastwood M, Sonnylal S, Denton CP, Abraham DJ, Leask A. Rac inhibition reverses the phenotype of fibrotic fibroblasts. PLoS One 2009, 4:e7438. 10.1371/journal.pone.0007438, 2757676, 19823586.
13. Parapuram SK, Shi-wen X, Elliott C, Welch ID, Jones H, Baron M, Denton CP, Abraham DJ, Leask A. Loss of PTEN expression by dermal fibroblasts causes skin fibrosis. J Invest Dermatol 2011, 131:1996-2003. 10.1038/jid.2011.156, 21654839.
14. Huang W, András IE, Rha GB, Hennig B, Toborek M. PPARα and PPARγ protect against HIV-1-induced MMP-9 overexpression via caveolae-associated ERK and Akt signaling. FASEB J 2011, 25:3979-3988. 10.1096/fj.11-188607, 21840940.
15. Leask A, Holmes A, Black CM, Abraham DJ. Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J Biol Chem 2003, 278:13008-13015. 10.1074/jbc.M210366200, 12571253.
16. Zhang M, Fraser D, Phillips A. ERK, p38, and Smad signaling pathways differentially regulate transforming growth factor-beta1 autoinduction in proximal tubular epithelial cells. Am J Pathol 2006, 169:1282-1293. 10.2353/ajpath.2006.050921, 1698849, 17003485.
17. Van Beek JP, Kennedy L, Rockel JS, Bernier SM, Leask A. The induction of CCN2 by TGFbeta1 involves Ets-1. Arthritis Res Ther 2006, 8:R36. 10.1186/ar1890, 1526589, 16469114.
18. Zhang W, Wu N, Li Z, Wang L, Jin J, Zha XL. PPARgamma activator rosiglitazone inhibits cell migration via upregulation of PTEN in human hepatocarcinoma cell line BEL-7404. Cancer Biol Ther 2006, 5:1008-1014. 10.4161/cbt.5.8.2887, 16775433.
19. De Val S, Ponticos M, Antoniv TT, Wells DJ, Abraham D, Partridge T, Bou-Gharios G. Identification of the key regions within the mouse pro-alpha 2(I) collagen gene far-upstream enhancer. J Biol Chem 2002, 277:9286-9292. 10.1074/jbc.M111040200, 11756428.
20. Fajardo OA, Thompson K, Parapuram SK, Liu S, Leask A. Mithramycin reduces expression of fibro-proliferative mRNAs in human gingival fibroblasts. Cell Prolif 2011, 44:166-173. 10.1111/j.1365-2184.2011.00738.x, 21401758.
21. Thompson K, Hamilton DW, Leask A. ALK5 inhibition blocks TGFβ-induced CCN2 expression in gingival fibroblasts. J Dent Res 2010, 89:1450-1454. 10.1177/0022034510379020, 20924066.